The 6-Minute Walk Test in Pulmonary Arterial Hypertension: How Far Is Enough?
Author:
- 1 September 2012
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 186 (5) , 396-397
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2011
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial HypertensionJACC, 2010
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- Ambrisentan for the Treatment of Pulmonary Arterial HypertensionCirculation, 2008
- Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2005
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996